Liver cancer is the third leading cancer killer in Hong Kong, with 1,447 deaths in 2021, accounting for 9.6 percent of all cancer-related deaths. Unfortunately, only one out of five patients is suitable for surgical resection treatment, and terminal patients are usually deemed unsuitable. However, there are advanced liver cancer patients in Hong Kong who successfully shrink their tumors after undergoing one year of immune combination therapy. They can then undergo resection surgery to ‘zero out’ the tumor. According to the Hong Kong Liver and Gastrointestinal Cancer Foundation, tumor removal surgery is the first choice treatment for early to mid-stage liver cancer. Surgery is not suitable if the tumor is too large, if it has invaded major blood vessels, or if cancer cells have spread. Immunotherapy activates autoimmunity against cancer cells....Read more https://www.theepochtimes.com/china/immune-combination-therapy-helps-patients-with-advanced-liver-cancer-recover-5506282